Educating patients with type 2 diabetes on a new class of drug, dipeptidyl peptidase 4 inhibitors.
Siminerio
Linda
L
University of Pittsburgh Diabetes Institute, Pittsburgh, PA, USA.
D058892:Adenosine Deaminase Inhibitors; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000523:psychology / Q000534:rehabilitation*; D018819:Dipeptidyl Peptidase 4; D054873:Dipeptidyl-Peptidase IV Inhibitors; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D006023:Glycoproteins / Q000037:antagonists & inhibitors*; D006801:Humans; D010349:Patient Compliance; D010353:Patient Education as Topic; D012944:Social Support
D058892:Adenosine Deaminase Inhibitors; D054873:Dipeptidyl-Peptidase IV Inhibitors; D004791:Enzyme Inhibitors; D006023:Glycoproteins; C042807:DPP4 protein, human; D018819:Dipeptidyl Peptidase 4